Vivus Reports EPS of $(0.19) vs. $(0.22)

VIVUS, Inc. VVUS today reported its highlights and financial results for the fourth quarter and year ended December 31, 2010. In the fourth quarter of 2009, net loss from continuing operations was of $15.5 million, or $0.19 per share, net income from discontinued operations of $2.3 million, or $0.03 per share, and total net loss of $13.2 million, or $0.16 per share. In the fourth quarter of 2009, research and development expenses included the expenses related to the preparation of the QNEXA NDA, which was filed in December 2009.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!